These findings elucidate a novel role of NEDD4L/GLS1/SLC1A5 axis in glutamine metabolism, and broaden our understanding of NEDD4L/GLS1/SLC1A5 axis in the progression of ESCC, which may benefit the treatment of ESCC. Here, SLC1A5 is linked to esophageal squamous cell carcinoma.